Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Modified-Release Drug Delivery Systems: Rate-Programmed II

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bone Fusion in the Cervical Spine: Where Are We Now?

Bioengineering (Basel, Switzerland)·2026

Same author

Harnessing Hydrogel Interaction with Functional Polymeric Nanoparticles for Sustained Co-Delivery of Therapeutics.

ACS biomaterials science & engineering·2026

Same author

Hydrogels for the treatment of spinal cord injury: progress and promise.

Nanomedicine (London, England)·2026

Same author

Modelling the impact of temperature on nanocarrier behavior: Thermodynamics, structural transitions, and drug release.

Advances in colloid and interface science·2026

Same author

Stromal Vascular Fraction Across Different Clinical Indications: A Pro-Regenerative <i>Fil Rouge</i>.

Journal of clinical medicine·2026

Same author

Rational design of microfluidic templated HA-LPEI nanogels for the targeted delivery of doxorubicin.

Journal of materials chemistry. B·2026

Search research articles

Related Experiment Video

Updated: May 22, 2026

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis

Published on: January 21, 2020

Bioresorbable polymer coated drug eluting stent: a model study.

Filippo Rossi¹, Tommaso Casalini, Edoardo Raffa

¹Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano , Via Mancinelli 7, 20131 Milano, Italy.

Molecular Pharmaceutics

|May 18, 2012

Summary

A new mathematical model simulates drug eluting stent performance, optimizing drug delivery and restenosis inhibition. This model enhances reliability and performance by analyzing polymer degradation and drug release dynamics.

More Related Videos

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Related Experiment Videos

Last Updated: May 22, 2026

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis

Published on: January 21, 2020

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Area of Science:

Biomedical Engineering
Materials Science
Pharmacology

Background:

Drug eluting stents (DES) require improved drug delivery systems for better control and reliability.
Traditional trial-and-error methods have limitations in optimizing DES performance.
Understanding polymer degradation, drug release, and restenosis inhibition is crucial for DES efficacy.

Purpose of the Study:

To develop and validate a model-based approach for simulating drug eluting stent performance.
To investigate the influence of stent design parameters on drug antirestenotic efficacy.
To provide a reliable tool for predicting in vitro and in vivo drug release.

Main Methods:

A mathematical model based on conservation equations was developed.
The model incorporates physical-chemical mechanisms of polymer degradation, drug release, and restenosis inhibition.
Model simulations were validated against literature data for parameter estimation reliability.

Main Results:

The model highlights the interdependence of factors influencing drug delivery and restenosis inhibition.
Stent design parameters were shown to significantly impact antirestenotic efficacy.
The model accurately simulates diffusional drug release under both in vitro and in vivo conditions.

Conclusions:

The developed mathematical model offers a reliable and efficient approach to optimize drug eluting stent design and performance.
The model's hierarchical structure allows for easy modifications to enhance accuracy in predicting restenosis evolution.
This computational tool provides immediate insights into system behavior with low resource requirements.